Drug Database
Back to search

Norway· NO-ID_931C1BD6-0CE5-43FA-AD82-EBD49989B40A

Gastrografin

A diatrizoic acid product containing meglumine amidotrizoate + sodium amidotrizoate, registered in Norway by 2care4 ApS. The same ATC class is registered in 9 of our 19 countries.

ATC V08AA01

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedGastrografinATCV08AA01REGISTER NO.NO-ID_931C1BD6-0CE5-4…PACKS LISTED3CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about meglumine amidotrizoate + sodium amidotrizoateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Diatrizoic acid is registered in 9 of 19 countries.

Countries holding a registration under ATC V08AA01 (diatrizoic acid), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 5 of them publish a price we can compare per daily dose
Search diatrizoic acid products by name

Diatrizoic acid · ATC V08AA01

9 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Meglumine Amidotrizoate + Sodium Amidotrizoate
Manufacturer
2care4 ApS
Country
Norway (NO)
ATC code
V08AA01
ATC class
Diatrizoic acid
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

1 priced
  • no_varenummer
    433945
    10 x 100
    NOK 1677.9
  • gtin
    7046264339459
  • no_merkevare_id
    ID_931C1BD6-0CE5-43FA-AD82-EBD49989B40A

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Diatrizoic acid in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All diatrizoic acid products

Authorised across Europe · EMA

The same active substance is authorised in 18 EEA countries. Names it is sold under:

  • Austria · Gastrografin
  • Bulgaria · Урографин
  • Germany · Gastrografin, Gastrolux
  • Spain · Amidotrizoato De Sodio Y Amidotrizoato De Meglumina Iberoinvesa Pharma, Gastrografin
  • Finland · Gastrografin
  • France · Gastrografine, Radioselectan Urinaire
  • United Kingdom (Northern Ireland) · Gastrografin, Urografin 150
  • Croatia · Gastrografin
  • Hungary · Gastrografin
  • Ireland · Gastrografin, Urografin
  • Italy · Gastrografin
  • Lithuania · Urografin
  • Latvia · Urografin
  • Netherlands · Gastrografin, Urografin
  • Poland · Gastrografin
  • Portugal · Gastrografina, Urografina
  • Sweden · Gastrografin
  • Slovakia · Urografin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5bd81a7e-9eb5-4023-bc34-272ab3556c95
GET /v1/drugs/5bd81a7e-9eb5-4023-bc34-272ab3556c95?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Mikstur/rektalvæske, oppløsning",
  "source": "fest",
  "status": "A",
  "atc_name": "Diatrizoinsyre",
  "merkevare_id": "ID_931C1BD6-0CE5-43FA-AD82-EBD49989B40A",
  "name_form_strength": "Gastrografin mikst/rektalvæske, oppl 0,1 g/ml/0,66 g/ml",
  "prescription_group": "C"
}
API referenceMCP serverPlans

See everything about diatrizoic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console